Health
Cardiovascular adverse events linked to hydroxychloroquine and chloroquine – News-Medical.Net
As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications.
Reviewed by Emily Henderson, B.Sc.Sep 23 2020
As the antimalarial drugs, hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications. A recent analysis published in the British Journal of Clinical Pharmacology provides new insights.
In the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting…
-
General18 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News24 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Business22 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Noosa News22 hours agoPalestine protesters forced into last-minute reroute